Diminazene Aceturate is indicated for the treatment of certain protozoal infections in animals, such as babesiosis and trypanosomiasis.

Babesiosis

Protozoal Infection

• Dosage varies based on the specific protozoal infection being treated and the weight of the animal.
• Administered by intramuscular or subcutaneous injection.

Adverse reactions may occur, with the most common listed first:

• Local Irritation at the Injection Site
• Transient Anorexia
• Vomiting
• Diarrhea
• Lethargy

Burning at injection site

Anorexia

Vomiting

Diarrhea

• Hypersensitivity: Monitor for signs of hypersensitivity reactions, and discontinue treatment if such reactions occur. Administer with caution in animals with known hypersensitivity to the drug.
• Injection Site Care: Use aseptic techniques during administration to minimize the risk of injection site abscess formation.
• Renal Impairment: Use with caution in animals with renal impairment, as diminazene aceturate is excreted primarily through the kidneys.
• Pregnancy and Lactation: Use cautiously in pregnant or lactating animals. Evaluate the risk-benefit profile before administration.
• Use in Young Animals: Safety and efficacy in very young animals may not be established. Exercise caution when treating neonates.